RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
EKF Diagnostics Holdings Stock

EKF Diagnostics Holdings P/S 2024

EKF Diagnostics Holdings P/S

2.57

Ticker

EKF.L

ISIN

GB0031509804

WKN

622434

As of Sep 18, 2024, EKF Diagnostics Holdings's P/S ratio stood at 2.57, a 7.53% change from the 2.39 P/S ratio recorded in the previous year.

The EKF Diagnostics Holdings P/S history

EKF Diagnostics Holdings Aktienanalyse

What does EKF Diagnostics Holdings do?

EKF Diagnostics Holdings PLC is a service business that offers a wide portfolio of diagnostics, medical devices, and point-of-care systems. It is an international company that sells its products in more than 100 countries worldwide. The company has offices in North America, Europe, and Asia-Pacific. EKF Diagnostics Holdings PLC was formed in 2010 through the merger of three diagnostic companies. The history of EKF Diagnostics Holdings PLC began in 1990 with the founding of Hemocontrol. This company developed innovative devices for monitoring blood coagulation in patients with red blood cell abnormalities. In 1995, Dade Behring Diagnostics (DBD) was established as a subsidiary of Hemocontrol, specializing in the manufacture and marketing of diagnostic products. DBD quickly became a major player in the global diagnostics market and was acquired by Siemens in 2006. In 2001, Pointe Scientific was founded, a company focused on the development and production of high-quality diagnostic tests and instruments. The current business model of EKF Diagnostics Holdings PLC is based on four key areas: Diabetes Care, Point-of-Care, Central Lab, and Life Sciences. All four areas aim to develop and offer innovative solutions for better patient care. The Diabetes Care segment offers diagnostic products for monitoring diabetes. It includes HemoScan, a device for measuring hemoglobin A1C, a test that measures blood sugar levels over several months, enabling the diagnosis and monitoring of diabetes. The Point-of-Care segment offers tests and devices for performing diagnoses and treatments directly at the point of care. This includes devices for measuring blood sugar and cholesterol, as well as devices for determining hemoglobin or troponin. The Central Lab segment offers a wide range of diagnostic tests and instruments for determining blood chemistry, hematology, and immunology. This includes autoanalyzers, hemoglobin counters, and blood glucose meters. The Life Sciences segment offers a wide range of diagnostic tests, instruments, and reagents. This includes tests for cancer diagnosis and monitoring thyroid function. The company offers a variety of products to ensure optimal patient care. This includes diagnostic tests for determining infectious diseases or monitoring chronic conditions. EKF Diagnostics Holdings PLC is a company that is constantly evolving and strives to offer innovative products and solutions. The company places great emphasis on research and development to stay at the forefront of the changing market. The company has an experienced team of technicians and scientists dedicated to the development, production, and marketing of diagnostic products. EKF Diagnostics Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding EKF Diagnostics Holdings's P/S Ratio

EKF Diagnostics Holdings's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing EKF Diagnostics Holdings's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating EKF Diagnostics Holdings's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in EKF Diagnostics Holdings’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about EKF Diagnostics Holdings stock

What is the price-to-earnings ratio of EKF Diagnostics Holdings?

The price-earnings ratio of EKF Diagnostics Holdings is currently 2.57.

How has the price-earnings ratio of EKF Diagnostics Holdings changed compared to last year?

The price-to-earnings ratio of EKF Diagnostics Holdings has increased by 7.53% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of EKF Diagnostics Holdings high compared to other companies?

Yes, the price-to-earnings ratio of EKF Diagnostics Holdings is high compared to other companies.

How does an increase in the price-earnings ratio of EKF Diagnostics Holdings affect the company?

An increase in the price-earnings ratio of EKF Diagnostics Holdings would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of EKF Diagnostics Holdings affect the company?

A decrease in the price-earnings ratio of EKF Diagnostics Holdings would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of EKF Diagnostics Holdings?

Some factors that influence the price-earnings ratio of EKF Diagnostics Holdings are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does EKF Diagnostics Holdings pay?

Over the past 12 months, EKF Diagnostics Holdings paid a dividend of 0.01 GBP . This corresponds to a dividend yield of about 4.4 %. For the coming 12 months, EKF Diagnostics Holdings is expected to pay a dividend of 0.01 GBP.

What is the dividend yield of EKF Diagnostics Holdings?

The current dividend yield of EKF Diagnostics Holdings is 4.4 %.

When does EKF Diagnostics Holdings pay dividends?

EKF Diagnostics Holdings pays a quarterly dividend. This is distributed in the months of December, December, December, December.

How secure is the dividend of EKF Diagnostics Holdings?

EKF Diagnostics Holdings paid dividends every year for the past 7 years.

What is the dividend of EKF Diagnostics Holdings?

For the upcoming 12 months, dividends amounting to 0.01 GBP are expected. This corresponds to a dividend yield of 4.01 %.

In which sector is EKF Diagnostics Holdings located?

EKF Diagnostics Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von EKF Diagnostics Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of EKF Diagnostics Holdings from 12/1/2023 amounting to 0.012 GBP, you needed to have the stock in your portfolio before the ex-date on 11/2/2023.

When did EKF Diagnostics Holdings pay the last dividend?

The last dividend was paid out on 12/1/2023.

What was the dividend of EKF Diagnostics Holdings in the year 2023?

In the year 2023, EKF Diagnostics Holdings distributed 0.012 GBP as dividends.

In which currency does EKF Diagnostics Holdings pay out the dividend?

The dividends of EKF Diagnostics Holdings are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von EKF Diagnostics Holdings

Our stock analysis for EKF Diagnostics Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EKF Diagnostics Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.